๐Ÿ“ก TrialPulse
COMPLETEDโš  Results delaymediumPHASE1

A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection

NCT06095427ยทShandong Boan Biotechnology Co., Ltdยทsource: ClinicalTrials.gov โ†—ยทupdated 2026-10-19
Active bottleneck signal โ€” evidence, not a confirmed violation
โš  Results delay+951dmedium

Results not posted 951 days after primary completion + 365d (FDAAA 801 heuristic)

Registry history
Events detected for this trial โ€” severity ร— confidence ร— recency
Neon
How to read the confidence score: 1.0 = observed โ€” the registry record itself changed (a fact). <1.0 (e.g. 0.7) = signal โ€” inferred by a heuristic rule from the data; it flags something worth a look, it is not a confirmed finding. Values below are shown raw from the database; the highlighted parts are the actual values, dimmed parts are JSON syntax.
trial seenhigh2026-10-19
null โ†’ {"status":"COMPLETED","last_update_posted_at":"2026-10-19"}
Key dates
Start2021-03-09
Primary completion2023-03-14
Enrollment300actual
Results-delay signal
+951d
HealthyBIOLOGICAL
Site map
Per-site markers colored by site status
Live map
unknownParexel International GmbH, Early Phase Clinical Unit BerlinBerlin, Germany
unknownCTC North GmbH & Co KGHamburg, Germany